Stockscreener 앱 받기
38.97
0.46%
-0.18
Qiagen Nv 주식(QGEN)의 최신 뉴스
Qiagen stock holds its identity. Investors watch the business profile. - AD HOC NEWS
Qiagen N.V. focuses on molecular testing as investors watch global diagnostics demand - AD HOC NEWS
Qiagen N.V. focuses on diagnostics growth and US exposure - AD HOC NEWS
Qiagen N.V. business update amid global diagnostics demand - AD HOC NEWS
Qiagen N.V. highlights its role in global diagnostics as investors track long-term growth - AD HOC NEWS
Qiagen N.V. focuses on molecular diagnostics and long-term growth - AD HOC NEWS
Environmental DNA Market Set to Surge to USD 5.61 Billion by 2031 with 10.2% CAGR - GlobeNewswire Inc.
Qiagen N.V. highlights molecular diagnostics growth as investors eye global health demand - AD HOC NEWS
Qiagen N.V. outlines its diagnostics edge as a global life sciences player - AD HOC NEWS
How Investors Are Reacting To Qiagen (QGEN) Joining The Russell 1000 Dynamic Index - simplywall.st
Qiagen N.V. highlights its role in molecular diagnostics as investors track the stock - AD HOC NEWS
Price to earnings forward of Qiagen N.V. – NYSE:QGEN - TradingView
Qiagen N.V. highlights its diagnostics reach as investors weigh long-term demand - AD HOC NEWS
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen N.V. highlights diagnostics role amid steady investor interest - AD HOC NEWS
QGENQiagen NV Short Interest - Finviz
Barclays Maintains Qiagen NV(QGEN.US) With Hold Rating, Maintains Target Price $38 - 富途牛牛
Qiagen N.V. outlines long-term growth drivers as diagnostics demand expands - AD HOC NEWS
Qiagen N.V. highlights digital PCR expansion. Stock trades near recent highs on Nasdaq - AD HOC NEWS
Qiagen earnings calendar and diagnostics pipeline, shares watched by international investors - AD HOC NEWS
Qiagen earnings calendar stands out this week, shares steady on Xetra - AD HOC NEWS
Qiagen steady ahead of earnings, shares watched by analysts - AD HOC NEWS
Is Qiagen (QGEN) Undervalued Following Its Index Addition And QIAcuity Expansion? - Sahm
QIAGEN NV Actuals & Estimates (TURQUOISE:QIAD) - TradingView
The QIAamp DNA Mini Kit from Qiagen N.V.quiet lab workhorse for clean samples - AD HOC NEWS
Qiagen N.V.(NYSE: QGEN) added to Russell 1000 Dynamic Index - marketscreener.com
Qiagen consistent with diagnostics strategy, shares follow sector trend - AD HOC NEWS
QIAGEN NV Actuals & Estimates (AQUISUK:QIAD) - TradingView
Qiagen expands QIAcuity gene expression tools, shares remain muted on NYSE - AD HOC NEWS
QIAGEN NV Actuals & Estimates (VIE:QGE4) - TradingView
Qiagen N.V. refines diagnostics portfolio, shares backed by long-term strategy - AD HOC NEWS
Qiagen steadies after recent pullback, shares tracked on NYSE and Xetra - Ad-hoc-news.de
Enterprise value to EBIT forward of Qiagen N.V. – NYSE:QGEN - TradingView
Qiagen updates its diagnostics focus, shares anchored in health-care demand - AD HOC NEWS
QGEN Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Qiagen N.V. – NYSE:QGEN - TradingView
Qiagen earnings calendar and diagnostics outlook, shares in focus for Nasdaq investors - AD HOC NEWS
Qiagen extends its recent high, shares near 52-week peak on NYSE and Xetra - AD HOC NEWS
QIAGEN NV Actuals & Estimates (BIVA:QIA/N) - TradingView
Qiagen N.V. updates earnings calendar, shares tracked against diagnostics peers - AD HOC NEWS
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView
Managers' transactions announcement according to article 19 MAR - TradingView
Qiagen adjusts portfolio in Europe, shares track diagnostics peers - Ad-hoc-news.de
QIAGEN NV Actuals & Estimates (NYSE:QGEN) - TradingView
Qiagen publishes new sustainability report, shares backed by fresh analyst support - Ad-hoc-news.de
Enterprise value to EBITDA forward of Qiagen N.V. – NYSE:QGEN - TradingView
Kepler Cheuvreux Initiates Qiagen Coverage at Hold - marketscreener.com
Is Qiagen's (QGEN) Digital PCR Expansion Quietly Redefining Its Competitive Moat in Biopharma Tools? - simplywall.st
Qiagen N : Sustainability Report (ca ab 1305 voluntary carbon market disclosure 2026) - marketscreener.com
Qiagen N : Sustainability Report (ca ab 1305 voluntary carbon market disclosure) - marketscreener.com
Qiagen NV Annual Shareholders Meeting Transcript - GuruFocus
Morgan Stanley Upgrades Qiagen to Overweight, Raises PT - marketscreener.com
QGEN Upgraded by Morgan Stanley -- Price Target Raised to $42.00 - GuruFocus
Qiagen annual meeting in Venlo, shares under DAX investor scrutiny - Ad-hoc-news.de
Qiagen updates draw analyst attention, shares react on NYSE and Xetra - Ad-hoc-news.de
Qiagen Raised to Overweight From Equal-Weight by Morgan Stanley - Moomoo
Qiagen gets a DZ Bank lift, analyst consensus shapes the shares - Ad-hoc-news.de
QIAGEN NV : Gets a Buy rating from DZ Bank - marketscreener.com
Qiagen NV (QGEN) Institutional Confidence - TradingKey
Morgan Stanley Upgrades Qiagen NV(QGEN.US) to Buy Rating, Raises Target Price to $42 - Moomoo
Qiagen strategy and digital PCR expansion, shares tracked on Xetra and NYSE - AD HOC NEWS
Qiagen NV: QIAGEN N.V.Share Consolidation/Cash Distribution Option Symbol: QGEN New Symbol: QGEN1 - Moomoo
Qiagen Stockweekly outlook with earnings ahead - AD HOC NEWS
Qiagen NV (QGEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
0.41%
0.29%
자본화:
|
볼륨(24시간):